What Researchers Did
Researchers described a case where adjunctive hyperbaric oxygen therapy was used to treat a diabetic patient with refractory malignant otitis externa.
What They Found
A 55-year-old man with diabetes and malignant otitis externa, unresponsive to high-dose moxalactam disodium, experienced resolution of his Pseudomonas aeruginosa infection. This occurred after adjunctive hyperbaric oxygen therapy was added to his treatment regimen.
What This Means for Canadian Patients
For Canadian patients with refractory malignant otitis externa, adjunctive hyperbaric oxygen therapy might be a viable treatment option. This approach could offer a solution when standard antibiotic therapies prove ineffective.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a single case report, the findings of this study cannot be generalized to a broader patient population.